CytoMed Therapeutics Ltd Live Stock Price Today, Share Analysis and Chart

Name: CytoMed Therapeutics Ltd: Is Infosys Ltd. worth buying?
Item: CytoMed Therapeutics Ltd
Rating: 1.23458325
Author: Trendlyne DVM scores

about

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of inna...

1.98 0.03 (1.54%)

51.11% Fall from 52W High

16,813

XNAS Volume

XNAS 10 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

5.3 / 100

Technically Neutral

44.1 / 100

1Yr Price target upside is 153%

1 analysts

CytoMed Therapeutics Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..